Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis

The Journal of biological chemistry (2013) - Comments
pubmed: 23687298 doi: 10.1074/jbc.m113.477216 issn: 0021-9258 issn: 1083-351x

Tzu-Hua Lin, Soo Ok Lee, Yuanjie Niu, Defeng Xu, Liang Liang, Lei Li, Shauh-Der Yeh, Naohiro Fujimoto, Shuyuan Yeh, Chawnshang Chang